This video describes the Xeomin
(incobotulinumtoxinA) active
ingredient manufacturing process
and removal of complexing proteins
from the active neurotoxin.
Xeomin's active ingredient is
derived from Hall-Strain
Clostridium botulinum serotype
A. But the difference is
in how the active neurotoxin is
purified.
Through state-of-the-art extract
technology, the active neurotoxin
in Xeomin is isolated, using
the multi-step process of
chromatography that uniquely
purifies the molecule, removing
the complexing proteins, leaving
just the active therapeutic
components.